The association between an inflammation-based nutritional tool (Glasgow Prognostic Score) and length of hospital stay in patients with haematological cancer.

IF 2.8 3区医学 Q2 HEALTH CARE SCIENCES & SERVICES

Supportive Care in Cancer Pub Date : 2024-11-19 DOI:10.1007/s00520-024-09021-0

Anqi Song, Beiwen Ni, Molian Tang, Yiquan Zhou, Xiaomin Zhang, Zhiqi Chen, Lijing Shen, Renying Xu

{"title":"The association between an inflammation-based nutritional tool (Glasgow Prognostic Score) and length of hospital stay in patients with haematological cancer.","authors":"Anqi Song, Beiwen Ni, Molian Tang, Yiquan Zhou, Xiaomin Zhang, Zhiqi Chen, Lijing Shen, Renying Xu","doi":"10.1007/s00520-024-09021-0","DOIUrl":null,"url":null,"abstract":"Background: This is a retrospective study to identify if Glasgow Prognostic Score (GPS) is associated with length of hospital stay (LOS) in haematological cancer.Methods: The participants were adult inpatients at a single centre in between 2018 and 2022. Serum levels of CRP and albumin were measured at admission. GPS was calculated as follows: point \"0\" as CRP < 10 mg/L and albumin ≥ 35 g/L; point \"2\" as CRP ≥ 10 mg/L and albumin < 35 g/L; point \"1\" as either CRP ≥ 10 mg/L or albumin < 35 g/L. Patients with point \"0\" were classified as low risk whilst point \"2\" as high risk. LOS was defined as the interval between the admission and discharge date.Results: As a result, the average age was 59.6 ± 12.6 years and the average LOS was 6.0 days (IQR = 2 days, 11 days). Of 1621 patients, 8.8% of them were high risk. GPS was associated with LOS (β = 2.7 days; 95% CI = 0.8 days, 4.6 days; p trend < 0.001) after full adjustment. Each point of GPS was associated with 1.9 days (95% CI = 1.4 days, 2.4 days) longer in LOS with full adjustment. The association was more prominent in younger patients (< 65 years), patients with leukaemia and myelodysplastic syndrome, and those with normal body weight status (18.5-24 kg/m2), compared with their counterparts.Conclusion: GPS was associated with LOS in Chinese patients with haematological cancer, indicating GPS could be a useful tool to predict outcome.","PeriodicalId":22046,"journal":{"name":"Supportive Care in Cancer","volume":"32 12","pages":"804"},"PeriodicalIF":2.8000,"publicationDate":"2024-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Supportive Care in Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00520-024-09021-0","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}

引用次数: 0

Abstract

Background: This is a retrospective study to identify if Glasgow Prognostic Score (GPS) is associated with length of hospital stay (LOS) in haematological cancer.

Methods: The participants were adult inpatients at a single centre in between 2018 and 2022. Serum levels of CRP and albumin were measured at admission. GPS was calculated as follows: point "0" as CRP < 10 mg/L and albumin ≥ 35 g/L; point "2" as CRP ≥ 10 mg/L and albumin < 35 g/L; point "1" as either CRP ≥ 10 mg/L or albumin < 35 g/L. Patients with point "0" were classified as low risk whilst point "2" as high risk. LOS was defined as the interval between the admission and discharge date.

Results: As a result, the average age was 59.6 ± 12.6 years and the average LOS was 6.0 days (IQR = 2 days, 11 days). Of 1621 patients, 8.8% of them were high risk. GPS was associated with LOS (β = 2.7 days; 95% CI = 0.8 days, 4.6 days; p trend < 0.001) after full adjustment. Each point of GPS was associated with 1.9 days (95% CI = 1.4 days, 2.4 days) longer in LOS with full adjustment. The association was more prominent in younger patients (< 65 years), patients with leukaemia and myelodysplastic syndrome, and those with normal body weight status (18.5-24 kg/m²), compared with their counterparts.

Conclusion: GPS was associated with LOS in Chinese patients with haematological cancer, indicating GPS could be a useful tool to predict outcome.

查看原文本刊更多论文

基于炎症的营养工具（格拉斯哥预后评分）与血液肿瘤患者住院时间的关系。

背景：这是一项回顾性研究，旨在确定格拉斯哥预后评分（GPS）是否与血液肿瘤患者的住院时间（LOS）相关：这是一项回顾性研究，旨在确定格拉斯哥预后评分（GPS）是否与血液肿瘤患者的住院时间（LOS）相关：参与者为2018年至2022年期间在一个中心住院的成人患者。入院时测量血清 CRP 和白蛋白水平。GPS 的计算方法如下：点 "0 "为 CRP 结果：结果：平均年龄为 59.6 ± 12.6 岁，平均住院日为 6.0 天（IQR = 2 天，11 天）。在 1621 名患者中，8.8% 属于高危人群。与同类患者相比，GPS与住院时间相关（β = 2.7天；95% CI = 0.8天，4.6天；P趋势2）：结论：GPS与中国血液肿瘤患者的生命周期有关，表明GPS是预测预后的有用工具。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Supportive Care in Cancer 医学-康复医学

CiteScore

5.70

自引率

9.70%

发文量

751

审稿时长

3 months

期刊介绍： Supportive Care in Cancer provides members of the Multinational Association of Supportive Care in Cancer (MASCC) and all other interested individuals, groups and institutions with the most recent scientific and social information on all aspects of supportive care in cancer patients. It covers primarily medical, technical and surgical topics concerning supportive therapy and care which may supplement or substitute basic cancer treatment at all stages of the disease. Nursing, rehabilitative, psychosocial and spiritual issues of support are also included.